Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

NCT06999434 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06999434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06999434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Recruiting
Start date
May 5, 2025
Completion date
May 5, 2030
Enrollment
105 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease (ad), demyelinating disorders, mci, ms (multiple sclerosis), sci - spinal cord injury, spinal radiculopathy